Centivax Secures $37 Million to Propel Universal Flu Vaccine and Further Pipeline Development#United_States#South_San_Francisco#Centivax#Universal_Immunity#Centi-Flu_01
Centivax Secures $37 Million to Propel Universal Flu Vaccine and Further Pipeline Development
Centivax, Inc. has successfully closed a $37 million financing round, advancing its universal flu vaccine, Centi-Flu 01, towards Phase 2 clinical trials while expanding its innovative therapeutic pipeline.
third-news.com
March 30, 2026 at 1:10 PM
Centivax Secures $37 Million to Propel Universal Flu Vaccine and Further Pipeline Development#United_States#South_San_Francisco#Centivax#Universal_Immunity#Centi-Flu_01
Centivax Secures $45 Million Funding to Develop Universal Flu Vaccine and Expand Immunology Portfolio#United_States#South_San_Francisco#Vaccine_Development#Centivax#Universal_Immunity
Centivax Secures $45 Million Funding to Develop Universal Flu Vaccine and Expand Immunology Portfolio
Centivax Inc. has successfully raised $45 million in an oversubscribed Series A funding round aimed at developing a universal flu vaccine and expanding their immunology portfolio.
third-news.com
July 8, 2025 at 8:23 PM
Centivax Secures $45 Million Funding to Develop Universal Flu Vaccine and Expand Immunology Portfolio#United_States#South_San_Francisco#Vaccine_Development#Centivax#Universal_Immunity